M Stöckle

2.8k total citations
29 papers, 597 citations indexed

About

M Stöckle is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, M Stöckle has authored 29 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 14 papers in Epidemiology and 14 papers in Hepatology. Recurrent topics in M Stöckle's work include Hepatitis C virus research (14 papers), HIV/AIDS drug development and treatment (14 papers) and HIV Research and Treatment (9 papers). M Stöckle is often cited by papers focused on Hepatitis C virus research (14 papers), HIV/AIDS drug development and treatment (14 papers) and HIV Research and Treatment (9 papers). M Stöckle collaborates with scholars based in Switzerland, United States and United Kingdom. M Stöckle's co-authors include Andri Rauch, Enos Bernasconi, Gilles Wandeler, Alexandra Calmy, Huldrych F. Günthard, Hansjakob Furrer, Andrea Bregenzer, Thomas Gsponer, Olivier Clerc and Matthias Cavassini and has published in prestigious journals such as Annals of Internal Medicine, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

M Stöckle

27 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Stöckle Switzerland	12	386	285	281	116	92	29	597
Alexandra Scherrer Switzerland	15	213 0.6×	86 0.3×	380 1.4×	55 0.5×	273 3.0×	37	591
Angiola Spinetti Italy	12	711 1.8×	758 2.7×	358 1.3×	100 0.9×	82 0.9×	21	949
Carolyn Brandt United States	11	307 0.8×	50 0.2×	250 0.9×	106 0.9×	117 1.3×	17	579
Christian Kollan Germany	13	333 0.9×	46 0.2×	445 1.6×	44 0.4×	224 2.4×	43	570
Iain Reeves United Kingdom	12	220 0.6×	67 0.2×	173 0.6×	27 0.2×	34 0.4×	29	357
Hugues Aumaître France	7	359 0.9×	324 1.1×	88 0.3×	17 0.1×	25 0.3×	19	497
P Dallacasa Italy	12	318 0.8×	139 0.5×	419 1.5×	186 1.6×	309 3.4×	16	792
Sunanda Gaur United States	12	165 0.4×	33 0.1×	188 0.7×	49 0.4×	112 1.2×	47	469
Antoni Jou Spain	15	339 0.9×	105 0.4×	543 1.9×	232 2.0×	484 5.3×	23	904
P. de Truchis France	10	201 0.5×	41 0.1×	351 1.2×	147 1.3×	251 2.7×	20	589

Countries citing papers authored by M Stöckle

Since Specialization

Citations

This map shows the geographic impact of M Stöckle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Stöckle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Stöckle more than expected).

Fields of papers citing papers by M Stöckle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Stöckle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Stöckle. The network helps show where M Stöckle may publish in the future.

Co-authorship network of co-authors of M Stöckle

This figure shows the co-authorship network connecting the top 25 collaborators of M Stöckle. A scholar is included among the top collaborators of M Stöckle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Stöckle. M Stöckle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Béguelin, Charles, Bernard Surial, Aline Munting, et al.. (2025). Frequent hepatitis B surface antigen ( HBsAg) clearance during tenofovir therapy in persons with HIV /hepatitis B virus coinfection. HIV Medicine. 26(5). 813–819.

Braun, Dominique L., Andri Rauch, M Stöckle, et al.. (2024). Characterization and Determinants of Long-Term Immune Recovery Under Suppressive Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 96(1). 68–76. 1 indexed citations

Thorball, Christian W., Jacques Fellay, Karin J. Metzner, et al.. (2024). Using viral diversity to identify HIV-1 variants under HLA-dependent selection in a systematic viral genome-wide screen. PLoS Pathogens. 20(8). e1012385–e1012385. 1 indexed citations

Huber, Michael, Kathrin Neumann, Julia Notter, et al.. (2024). Genetic Diversity From Proviral DNA as a Proxy for Time Since HIV-1 Infection. The Journal of Infectious Diseases. 230(3). e631–e636. 2 indexed citations

Künzler‐Heule, Patrizia, Axel J. Schmidt, Katharina Fierz, et al.. (2023). Exploring group differences in the response to a sexual risk reduction intervention to prevent hepatitis C virus reinfection in HIV-infected MSM: a mixed-methods study. AIDS Care. 36(4). 442–451. 2 indexed citations

Boyd, Anders, Luisa Salazar‐Vizcaya, Franziska Suter‐Riniker, et al.. (2023). Long‐term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir‐containing antiretroviral therapy. HIV Medicine. 25(2). 291–298. 2 indexed citations

Boyd, Anders, Amanda Mocroft, Katharina Kusejko, et al.. (2022). Low Risk of Failing Direct-Acting Antivirals in People With Human Immunodeficiency Virus/Hepatitis C Virus From Sub-Saharan Africa or Southeastern Asia: A European Cross-Sectional Study. Open Forum Infectious Diseases. 9(10). ofac508–ofac508.

Surial, Bernard, Catrina Mugglin, Alexandra Calmy, et al.. (2021). Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV. Annals of Internal Medicine. 174(6). 758–767. 79 indexed citations

Surial, Bernard, Nicolas Bertholet, Jean‐Bernard Daeppen, et al.. (2021). The Impact of Binge Drinking on Mortality and Liver Disease in the Swiss HIV Cohort Study. Journal of Clinical Medicine. 10(2). 295–295. 11 indexed citations

10.

Hampel, Benjamin, Katharina Kusejko, Roger D. Kouyos, et al.. (2019). Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017. HIV Medicine. 21(4). 228–239. 51 indexed citations

11.

Künzler‐Heule, Patrizia, Sandra Engberg, Manuel Battegay, et al.. (2019). Screening HIV-positive men who have sex with men for hepatitis C re-infection risk: is a single question on condom-use enough? A sensitivity analysis. BMC Infectious Diseases. 19(1). 821–821. 6 indexed citations

12.

Aebi‐Popp, Karoline, Gilles Wandeler, Luisa Salazar‐Vizcaya, et al.. (2018). Rapid decline of anti‐hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV‐infected men who have sex with men. HIV Medicine. 19(6). 420–425. 13 indexed citations

13.

Hinić, Vladimira, Helena M. B. Seth-Smith, M Stöckle, Daniel Goldenberger, & Adrian Egli. (2018). First report of sexually transmitted multi-drug resistant Shigella sonnei infections in Switzerland, investigated by whole genome sequencing. Swiss Medical Weekly. 148(3334). w14645–w14645. 7 indexed citations

14.

Buser, Andreas, M Stöckle, Hans H. Hirsch, et al.. (2017). Specificity of two HIV screening tests detecting simultaneously HIV-1 p24 antigen and antibodies to HIV-1 and −2. Journal of Virological Methods. 249. 143–146. 8 indexed citations

15.

Salazar‐Vizcaya, Luisa, Roger D. Kouyos, Jan Fehr, et al.. (2017). On the potential of a short‐term intensive intervention to interrupt HCV transmission in HIV‐positive men who have sex with men: A mathematical modelling study. Journal of Viral Hepatitis. 25(1). 10–18. 13 indexed citations

16.

Kovari, Helen, Bruno Ledergerber, Matthias Cavassini, et al.. (2015). High hepatic and extrahepatic mortality and low treatment uptake in HCV-coinfected persons in the Swiss HIV cohort study between 2001 and 2013. Journal of Hepatology. 63(3). 573–580. 30 indexed citations

17.

Kovari, Helen, Stefan Russmann, Bruno Ledergerber, et al.. (2015). Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study. PLoS ONE. 10(7). e0133879–e0133879. 5 indexed citations

18.

Bertisch, Barbara, Silvia Franceschi, M. Lise, et al.. (2013). Risk Factors for Anal Cancer in Persons Infected With HIV: A Nested Case-Control Study in the Swiss HIV Cohort Study. American Journal of Epidemiology. 178(6). 877–884. 96 indexed citations

19.

Wandeler, Gilles, Thomas Gsponer, Andrea Bregenzer, et al.. (2012). Hepatitis C Virus Infections in the Swiss HIV Cohort Study: A Rapidly Evolving Epidemic. Clinical Infectious Diseases. 55(10). 1408–1416. 176 indexed citations

20.

Stöckle, M, Luigia Elzi, Jürgen K. Rockstroh, & Manuel Battegay. (2012). Morbidität und Mortalität der HIV-Infektion. Der Internist. 53(10). 1151–1156. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact